Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Amplicore, Inc. Announces Closing of a Successful $4M Seed Funding Round 2021-03-26 05:19
Antengene Appoints Kevin Lynch as Chief Medical Officer 2021-03-25 23:26
Antengene Appoints Bo Shan as Chief Scientific Officer 2021-03-25 22:36
CStone Pharmaceuticals Reports Financial Results and Business Highlights for Full-year 2020 2021-03-25 22:03
BioNTech Chairman Helmut Jeggle joins the Board of IQM Quantum Computers 2021-03-25 18:29
AllianThera Biopharma comes out of stealth and collaborates on AI with Insilico Medicine 2021-03-25 17:00
Nippon Express Obtains IATA CEIV Pharma Certification for Temperature-controlled Facility near Narita Airport 2021-03-25 15:00
Positive Phase III Clinical Results for EirGenix's Proposed Trastuzumab Biosimilar 2021-03-24 23:27
Ascentage Pharma's First Third-Generation BCR-ABL Inhibitor in China Olverembatinib (HQP1351) Recommended for Breakthrough Therapy Designation 2021-03-24 19:07
Forest Hills Lab is filing an IND to initiate a clinical phase 2 study on Parkinson's disease with the US FDA 2021-03-24 12:25
CStone Announces New Drug Approval of GAVRETO(R) (pralsetinib) as First Selective RET Inhibitor in China, Providing a New Therapy for a Subset of Non-Small Cell Lung Cancer Patients 2021-03-24 10:46
Adults with obesity treated with semaglutide 2.4 mg achieved and maintained a significant amount of weight loss in a 68-week trial 2021-03-24 04:41
Pharma Industry to Spend $4.5 Billion on Digital Transformation by 2030 2021-03-23 16:00
Diluent or Immuno-Reagent solutions for your diagnostic testing kits (Covid, Flu, etc.) 2021-03-23 15:04
Taiko Pharmaceutical Officially Launches "Cleverin" in Mexico, Top Made-in-Japan Brand for Removing Viruses/Bacteria, Deodorization 2021-03-23 14:00
CanSinoBIO Announces Approval for its Single-Dose COVID-19 Vaccine Convidecia™ in Hungary 2021-03-23 00:43
Xylonix Reveals New Drug Compound for Combating Cancer and Abnormal Macrophages 2021-03-22 21:00
RedHill Biopharma Announces Compassionate Use Treatment with Opaganib of first COVID-19 Patients in Switzerland 2021-03-22 19:00
Everest Medicines Announces Acceptance of New Drug Application by China NMPA for Xerava(TM) for the Treatment of Complicated Intra-abdominal Infections 2021-03-22 10:40
Harbour BioMed Announces Dosing of First Patient in Phase I Clinical Study of its Next-Generation Anti-CTLA-4 Antibody in China 2021-03-22 10:31
1 125 126 127 128 129 229